Net Change In Cash - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ryvu Therapeutics SA
Net Change in Cash Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Net Change in Cash
-zł171.1m
CAGR 3-Years
N/A
CAGR 5-Years
-21%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Net Change in Cash
zł37k
CAGR 3-Years
-76%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Medicofarma Biotech SA
WSE:MDB
Net Change in Cash
-zł504.8k
CAGR 3-Years
-133%
CAGR 5-Years
-119%
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Net Change in Cash
-zł7.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Net Change in Cash?
Net Change in Cash
-171.1m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Net Change in Cash amounts to -171.1m PLN.

What is Ryvu Therapeutics SA's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-21%

Back to Top